1
/
of
1
Medical Education Hub
Cedars Sinai 18th Annual Women and Ischemic Heart Disease Symposium 2024
Cedars Sinai 18th Annual Women and Ischemic Heart Disease Symposium 2024
Regular price
€20,00 EUR
Regular price
Sale price
€20,00 EUR
Taxes included.
Shipping calculated at checkout.
Quantity
Couldn't load pickup availability
Cedars Sinai 18th Annual Women and Ischemic Heart Disease Symposium 2024
- Include: 18 videos + 9 pdfs, size: 4.37 GB
- Target Audience: obstetrics & gynecology physician, cardiologist
- Sample video: contact me for sample video
Date & Location
Friday, April 12, 2024, 7:30 AM – 2:10 PM PST, Cedars-Sinai Medical Center, Los Angeles, CA
Target Audience
Specialties – Cardiology, Emergency Medicine, Endocrinology & Metabolism, Family / General Medicine, Internal Medicine, Obstetrics & Gynecology, Preventive Medicine
Professions – Nurse, Nurse (Advanced Practice NP CRNA CNM CNS), Physician, Physician Assistant
Overview
The 18th Annual Women and Ischemic Heart Disease Symposium will explore sex and gender-specific issues in women’s cardiovascular health, including prevention using life’s essential 8, cholesterol management, GLP RA for treatment of Obesity, Hormones, heart failure detection, diagnosis, and management, Postural Orthostatic Tachycardia Syndrome, and Coronary Microvascular Disease.
Objectives
- Identify the social determinants that can influence women’s health to more effectively communicate with patients about health-related conditions and behaviors
- Apply best practices in screening young women for heart disease and managing women with heart disease, obesity and diabetes
- Explore sex differences in medicine, including remote monitoring, adherence, and symptomatic conditions
Topics:
- Agenda.pdf
- CASES- Postural Orthostatic Tachycardia Syndrome Q&A.mp4
- CASES- Postural Orthostatic Tachycardia Syndrome.mp4
- CASES- Postural Orthostatic Tachycardia Syndrome.pdf
- Coronary Microvascular Disease- Access to Diagnosis Q&A.mp4
- Coronary Microvascular Disease- Access to Diagnosis.mp4
- Coronary Microvascular Disease- Access to Diagnosis.pdf
- Debate- GLP RA should be first line therapy for Treatment of Obesity 2.mp4
- Debate- GLP RA should be first line therapy for Treatment of Obesity Q&A 2.mp4
- Debate- GLP RA should be first line therapy for Treatment of Obesity.mp4
- Debate- GLP RA should be first line therapy for Treatment of Obesity.pdf
- Debate- Hormone Therapy and Cardiovascular Disease Q&A.mp4
- Debate- Hormone Therapy and Cardiovascular Disease.mp4
- Debate- Hormone Therapy and Cardiovascular Disease.pdf
- Debate- Hormone Therapy Why When We Should Say YES.mp4
- Dispelling the Myths- Women’s Cardiovascular Health Q&A.mp4
- Dispelling the Myths- Women’s Cardiovascular Health.mp4
- Dispelling the Myths- Women’s Cardiovascular Health.pdf
- Keynote Lecture- Sex differences in HF – detection, diagnosis, and management Q&A.mp4
- Keynote Lecture- Sex differences in HF – detection, diagnosis, and management.mp4
- Keynote Lecture- Sex differences in HF – detection, diagnosis, and management.pdf
- Prevention – Life’s Essential 8 Q&A.mp4
- Prevention – Life’s Essential 8.mp4
- Prevention – Life’s Essential 8.pdf
- Somethings Old, Somethings New- Cholesterol Management in 2024 Q&A.mp4
- Somethings Old, Somethings New- Cholesterol Management in 2024.mp4
- Somethings Old, Somethings New- Cholesterol Management in 2024.pdf
Share
